Difference between revisions of "Regimen classes"
Jump to navigation
Jump to search
m |
|||
| Line 3: | Line 3: | ||
=Anthracycline-based regimen= | =Anthracycline-based regimen= | ||
=Anti-CD20-based regimen= | =Anti-CD20-based regimen= | ||
| − | |||
| − | |||
=Endocrine-based regimen= | =Endocrine-based regimen= | ||
=Fluoropyrimidine-based regimen= | =Fluoropyrimidine-based regimen= | ||
| Line 15: | Line 13: | ||
=Trastuzumab-based regimen= | =Trastuzumab-based regimen= | ||
| + | =Tyrosine kinase inhibitor therapy= | ||
| + | =EGFR TKI therapy= | ||
[[Category:Ontology pages]] | [[Category:Ontology pages]] | ||
Revision as of 16:39, 12 January 2020
The purpose of this page is to define regimen classes that will be used in the HemOnc vocabulary; it is not for other purposes at this time.